Keudell Amgen Inc Transaction History

Keudell

$366 Million
Q3 2024

A detailed history of Keudell transactions in Amgen Inc stock. As of the latest transaction made, Keudell holds 4,046 shares of AMGN stock, worth $1.13 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

4,046

Previous 4,355 7.1%

Holding current value

$1.13 Million

Previous $1.36 Million 4.19%

% of portfolio

0.36%

Previous 0.4%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$309.38 - $337.38 $95,598 - $104,250	-309 Reduced 7.1%	4,046 $1.3 Million
Q2 2024 Jul 16, 2024	BUY	$262.75 - $319.31 $28,377 - $34,485	108 Added 2.54%	4,355 $1.36 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $28,769 - $34,727	-107 Reduced 2.46%	4,247 $1.21 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $136,288 - $153,749	-533 Reduced 10.91%	4,354 $1.25 Million
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $42,199 - $52,391	193 Added 4.11%	4,887 $1.31 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $255,838 - $302,523	1,194 Added 34.11%	4,694 $1.04 Million
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $69,994 - $85,312	310 Added 9.72%	3,500 $846,000
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $186,201 - $236,591	-813 Reduced 20.31%	3,190 $0
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $95,844 - $108,095	427 Added 11.94%	4,003 $902,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $9,459 - $10,526	41 Added 1.16%	3,576 $870,000
Q1 2022 Apr 18, 2022	SELL	$219.27 - $242.57 $14,910 - $16,494	-68 Reduced 1.89%	3,535 $855,000
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $103,019 - $117,896	518 Added 16.79%	3,603 $811,000
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $72,808 - $85,304	343 Added 12.51%	3,085 $656,000
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $34,803 - $38,611	149 Added 5.75%	2,742 $668,000
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $35,727 - $41,634	161 Added 6.62%	2,593 $645,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $8,655 - $10,306	40 Added 1.67%	2,432 $559,000
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $6,335 - $7,045	27 Added 1.14%	2,392 $608,000
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $17,209 - $21,118	87 Added 3.82%	2,365 $558,000
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $43,008 - $57,041	236 Added 11.56%	2,278 $462,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $56,195 - $72,230	297 Added 17.02%	2,042 $492,000
Q2 2019 Aug 23, 2019	BUY	$166.7 - $195.41 $290,891 - $340,990	1,745 New	1,745 $320,000
Q2 2019 Aug 21, 2019	SELL	$166.7 - $195.41 $324,231 - $380,072	-1,945 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$180.87 - $203.88 $351,792 - $396,546	1,945 New	1,945 $370,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account